Long-term use of AstraZeneca heart drug Brilinta has major benefits but some risks too
A keenly awaited clinical trial has revealed that long term use of AstraZeneca's drug Brilinta can reduce the risk of another heart attack or stroke, death in patients with a history of heart attacks by 16%. ...